RECRUITING

Reducing AIR Pollution Exposure to Lower Blood PRESSURE Among New York City Public Housing Residents

Talk to us

Conditions

Blood Pressureself-measured morning home systolic blood pressure (AM H-SBP)

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Fine particulate matter \<2.5 µm (PM2.5) air pollution is the fifth leading risk factor for global mortality, with the largest portion of deaths due to cardiovascular disease (CVD). While several mechanisms are responsible, PM2.5-induced elevations in blood pressure (BP) may be relevant. Indoor portable air cleaners (PACs) are a novel approach to reduce exposure to PM2.5 and potentially lower blood pressure. The current study is being conducted to provide evidence that PACs reduce PM2.5 exposure and lower systolic blood pressure (SBP) in key patient populations.

Official Title

Reducing AIR Pollution Exposure to Lower Blood PRESSURE Among New York City Public Housing Residents

Quick Facts

Study Start:2023-12-20
Study Completion:2028-03
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05874479

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 100 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * self-reported nonsmokers living in a nonsmoking household.
  2. * adults living with hypertension (HTN) from NYC public housing.
  1. * History of major known arrhythmias (e.g. atrial flutter or fibrillation, ventricular tachycardia).
  2. * Screening systolic BP ≥160 mm Hg or diastolic BP ≥100 mm Hg (i.e. severe hypertension by the 2017 ACC/AHA BP guideline).
  3. * A change in drug regimen in the prior 2 weeks or a planned change in drug regimen during the first 30 days for those taking antihypertensive medication.
  4. * Current smoking or living with an active smoker who smokes indoors
  5. * Planned travel out of NYC for ≥2 weeks in next 6 months
  6. * Incarcerated
  7. * Pregnant
  8. * Unable/unwilling to consent
  9. * Established cardiovascular disease
  10. * End-stage renal disease (chronic kidney disease stage IV or on dialysis)
  11. * Barrier to technology use (e.g., visual or hearing impairment)
  12. * Lung disease requiring oxygen
  13. * Cancer receiving treatment

Contacts and Locations

Study Contact

Jonathan Newman
CONTACT
(212) 263-9393
AirPressureNYC@nyulangone.org
Elle Anastasiou Pesante
CONTACT
(646) 501-3613
elle.anastasiou@nyulangone.org

Principal Investigator

Jonathan Newman
PRINCIPAL_INVESTIGATOR
NYU Langone Health

Study Locations (Sites)

NYU Langone Health
New York, New York, 10016
United States

Collaborators and Investigators

Sponsor: NYU Langone Health

  • Jonathan Newman, PRINCIPAL_INVESTIGATOR, NYU Langone Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-12-20
Study Completion Date2028-03

Study Record Updates

Study Start Date2023-12-20
Study Completion Date2028-03

Terms related to this study

Keywords Provided by Researchers

  • self-measured morning home systolic blood pressure (AM H-SBP)

Additional Relevant MeSH Terms

  • Blood Pressure